These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18508243)

  • 1. An MRI and proton spectroscopy study of the thalamus in children with autism.
    Hardan AY; Minshew NJ; Melhem NM; Srihari S; Jo B; Bansal R; Keshavan MS; Stanley JA
    Psychiatry Res; 2008 Jul; 163(2):97-105. PubMed ID: 18508243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
    Auer DP; Wilke M; Grabner A; Heidenreich JO; Bronisch T; Wetter TC
    Schizophr Res; 2001 Oct; 52(1-2):87-99. PubMed ID: 11595395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging.
    Rosenberg DR; Amponsah A; Sullivan A; MacMillan S; Moore GJ
    J Child Neurol; 2001 Sep; 16(9):636-41. PubMed ID: 11575601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
    Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
    Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls.
    Mirza Y; O'Neill J; Smith EA; Russell A; Smith JM; Banerjee SP; Bhandari R; Boyd C; Rose M; Ivey J; Renshaw PF; Rosenberg DR
    J Child Neurol; 2006 Feb; 21(2):106-11. PubMed ID: 16566872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M
    Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.
    Fitzgerald KD; Moore GJ; Paulson LA; Stewart CM; Rosenberg DR
    Biol Psychiatry; 2000 Feb; 47(3):174-82. PubMed ID: 10682215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalamic proton magnetic resonance spectroscopy in vegetative state induced by traumatic brain injury.
    Uzan M; Albayram S; Dashti SG; Aydin S; Hanci M; Kuday C
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):33-8. PubMed ID: 12486263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.
    Jakary A; Vinogradov S; Feiwell R; Deicken RF
    Schizophr Res; 2005 Jul; 76(2-3):173-85. PubMed ID: 15949650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalamic dysfunction in juvenile myoclonic epilepsy: a proton MRS study.
    Mory SB; Li LM; Guerreiro CA; Cendes F
    Epilepsia; 2003 Nov; 44(11):1402-5. PubMed ID: 14636347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray and white matter brain chemistry in young children with autism.
    Friedman SD; Shaw DW; Artru AA; Dawson G; Petropoulos H; Dager SR
    Arch Gen Psychiatry; 2006 Jul; 63(7):786-94. PubMed ID: 16818868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thalamic spectroscopy using magnetic resonance in autism].
    Perich-Alsina J; Aduna de Paz M; Valls A; Muñoz-Yunta JA
    Rev Neurol; 2002 Feb; 34 Suppl 1():S68-71. PubMed ID: 12447793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proton spectroscopy study of white matter in children with autism.
    Hardan AY; Fung LK; Frazier T; Berquist SW; Minshew NJ; Keshavan MS; Stanley JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Apr; 66():48-53. PubMed ID: 26593330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolite alterations in the hippocampus of high-functioning adult subjects with autism.
    Suzuki K; Nishimura K; Sugihara G; Nakamura K; Tsuchiya KJ; Matsumoto K; Takebayashi K; Isoda H; Sakahara H; Sugiyama T; Tsujii M; Takei N; Mori N
    Int J Neuropsychopharmacol; 2010 May; 13(4):529-34. PubMed ID: 19895725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylaspartate and epilepsy.
    Gadian DG
    Magn Reson Imaging; 1995; 13(8):1193-5. PubMed ID: 8750336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy of the brain in three cases of Rett syndrome: comparison with autism and normal controls.
    Hashimoto T; Kawano N; Fukuda K; Endo S; Mori K; Yoneda Y; Yamaue T; Harada M; Miyoshi K
    Acta Neurol Scand; 1998 Jul; 98(1):8-14. PubMed ID: 9696521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief report: biochemical correlates of clinical impairment in high functioning autism and Asperger's disorder.
    Kleinhans NM; Richards T; Weaver KE; Liang O; Dawson G; Aylward E
    J Autism Dev Disord; 2009 Jul; 39(7):1079-86. PubMed ID: 19234776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRS shows syndrome differentiated metabolite changes in human-generalized epilepsies.
    Savic I; Osterman Y; Helms G
    Neuroimage; 2004 Jan; 21(1):163-72. PubMed ID: 14741653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.